Evidence map›Paper›PMID 26806849›Full record

SynthesisScientific reports2016

A Bayesian framework systematic review and meta-analysis of anesthetic agents effectiveness/tolerability profile in electroconvulsive therapy for major depression.

Guillaume Fond, Djamila Bennabi, Emmanuel Haffen, Lore Brunel, Jean-Arthur Micoulaud-Franchi, Anderson Loundou, Christophe Lançon, Pierre-Michel Llorca, Pascal Auquier, Laurent Boyer

Registry-linked trialOpen access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04399070 (Effect of S-ketamine on Depressed Patients Undergoing Electroconvulsive Therapy-a Randomized, Double-blind, Controlled Clinical Study), which is not on this map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04399070 naunknown statusnot on this mapstarted 2020, after this paper: background citation

Effect of S-ketamine on Depressed Patients Undergoing Electroconvulsive Therapy-a Randomized, Double-blind, Controlled Clinical Study

TypeinterventionalSponsorYan QiuRan2020 to 2021Enrolled150ConditionsDepression, Bipolar, Depression, Unipolar, Major Depressive Disorder, Manic-Depressive - Now DepressedArmsS-ketamine, ketamine, saline
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Effect of ECT-anesthetics on reorientation time.European archives of psychiatry and clinical neuroscience · 2026
    Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Ketamine and depression: a narrative review.Drug design, development and therapy · 2019
    Review
  15. S -ketamine compared to etomidate during electroconvulsive therapy in major depression.European archives of psychiatry and clinical neuroscience · 2017
    Article
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Guillaume FondUniversité Paris Est-Créteil, Pôle de psychiatrie des hôpitaux universitaires H Mondor DHU Pe-PSY, INSERM U955, Eq Psychiatrie translationelle, Fondation FondaMental Fondation de coopération scientifique en santé mentale, Créteil, France.
Djamila BennabiDepartment of Clinical Psychiatry, CIC-1431, University Hospital of Besançon, EA Neurosciences 481, University of Franche-Comté, Besançon, France.
Emmanuel HaffenDepartment of Clinical Psychiatry, CIC-1431, University Hospital of Besançon, EA Neurosciences 481, University of Franche-Comté, Besançon, France.
Lore BrunelUniversité Paris Est-Créteil, Pôle de psychiatrie des hôpitaux universitaires H Mondor DHU Pe-PSY, INSERM U955, Eq Psychiatrie translationelle, Fondation FondaMental Fondation de coopération scientifique en santé mentale, Créteil, France.
Jean-Arthur Micoulaud-FranchiService d'explorations fonctionnelles du système nerveux, Clinique du sommeil, CHU de Bordeaux, Place Amélie Raba-Léon, 33076 Bordeaux, France.
Anderson LoundouAix-Marseille University, EA 3279 Research Unit - Public Health: Chronic diseases and quality of life, Marseille, France.
Christophe LançonService d'explorations fonctionnelles du système nerveux, Clinique du sommeil, CHU de Bordeaux, Place Amélie Raba-Léon, 33076 Bordeaux, France.
Pierre-Michel LlorcaNetwork of Expert centres, FondaMental Foundation, Créteil 94000, France.
Pascal AuquierAix-Marseille University, EA 3279 Research Unit - Public Health: Chronic diseases and quality of life, Marseille, France.
Laurent BoyerAix-Marseille University, EA 3279 Research Unit - Public Health: Chronic diseases and quality of life, Marseille, France.
Inserm · FRAix-Marseille Université · FRFondation FondaMental · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to assess the efficacy and tolerability/acceptability of 6 anesthetic agents in ECT for depressive disorders. We systematically reviewed 14 double-blind randomized controlled trials (610 participants). Efficacy was measured by the mean scores on validated depression scales at 6 ECT (or the nearest score if not available), number of responders at the end of treatment and seizure duration. The acceptability was measured by the proportion of patients who dropped out of the allocated treatment, and the tolerability by the number of serious adverse events and post-treatment cognition assessment. After excluding the trials responsible for heterogeneity, depression scores of patients who were administered methohexital were found to be significantly more improved than those who received propofol (p = 0.001). On the contrary, those who were administered propofol had lower depression scores than those with thiopental at the end of treatment (p = 0.002). Compared to propofol, methohexital was found to be significantly associated with higher seizure duration (p = 0.018). No difference was found for the acceptability profile (all p > 0.05). In summary, ketamine and methohexital may be preferred to propofol or thiopental in regard of effectiveness in depression scores and increased seizure duration. Further studies are warranted to compare ketamine and methohexital.

Indexed as

AnestheticsBayes TheoremElectroconvulsive TherapyElectroencephalographyHumansKetamineMajor Depressive DisorderMethohexitalRandomized Controlled Trials as TopicSeizuresAnestheticsKetamineMethohexital

Identifiers

PMID26806849
PMCPMC4726191
OpenAlexW2415192117

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.